The mortality follow-up in a cohort of German asphalt workers covered an additional 6 years. Male workers (N = 7919) were classified into four exposure categories: (1) exposure to bitumen only, (2) to bitumen and coal tar, (3) neither to tar nor to bitumen, and (4) unknown exposure. Exposure-specific standardized mortality ratios (SMR) and associated 95% confidence intervals (CI) based on age- and calendar period-specific national mortality rates were calculated. To compare exposed and unexposed workers, relative risks were estimated by Poisson regression. By the end of 2004, 835 workers had died. The SMR for lung cancer was 1.77 (95% CI 1.46-2.16). Head and neck cancer showed an SMR of 2.36 (95% CI 1.78-3.07). Bladder cancer mortality was elevated threefold. Significantly elevated cancer-related SMRs were also found for all malignant tumors. In addition, elevated mortality rates of nonmalignant causes such as alcoholism, liver cirrhosis, and unnatural causes of deaths including accidents were observed. After stratification by exposure group, cancer mortality was elevated among bitumen-exposed and unexposed subjects. In the internal analysis, the association between lung cancer and bitumen exposure was weakened as compared with the previous follow-up (relative risk [RR] = 1.15; 95% CI 0.72-1.84). The follow-up demonstrated an excess of cancer in this cohort of asphalt workers. However, the observed mortality patterns were not clear. Although exposure to bitumen cannot be ruled out as being responsible for the observed results, a higher prevalence of alcohol and tobacco consumption may partially explain the observed risk increases. Exposure assessment in future studies should account for multiple occupational agents and nonoccupational factors to rule out that the observed differences in SMR are not due simply to random variation.

Download full-text PDF

Source
http://dx.doi.org/10.1080/15459620903077682DOI Listing

Publication Analysis

Top Keywords

cancer mortality
12
mortality
8
asphalt workers
8
exposure bitumen
8
mortality rates
8
lung cancer
8
mortality elevated
8
exposure
7
bitumen
6
workers
6

Similar Publications

European cancer mortality predictions for the year 2025 with focus on breast cancer.

Ann Oncol

February 2025

Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy. Electronic address:

Background: We predicted the number of cancer deaths and rates for 2025 in the European Union (EU), its five most populous countries, and the UK, focusing on breast cancer.

Materials And Methods: We derived population data and death certificates for all cancers and major sites for the EU, France, Germany, Italy, Poland, Spain, and the UK since 1970, from the World Health Organization and United Nations databases. Estimates for 2025 were computed by linear regression on recent trends identified through Poisson joinpoint regression, considering the slope of the most recent trend segment.

View Article and Find Full Text PDF

[Merkel cell carcinoma: An update].

Bull Cancer

March 2025

Dermatologie, CHU de Tours, Tours, France; Réseau CARADERM, France.

Merkel cell carcinoma (MCC) is a rare skin cancer that mainly affects the elderly, and whose incidence is increasing. Although the exact origin of this cancer remains uncertain, research in recent years has revealed that MCC develops through two oncogenesis pathways: virally induced by the Merkel polyomavirus (80% of cases) and induced by mutations linked to ultraviolet rays (20% of cases). MCC is an aggressive cancer, with a high mortality rate and limited therapeutic options in advanced stage.

View Article and Find Full Text PDF

Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide. This study aimed to explore the role of hsa-miR-101-3p in HCC pathogenesis by identifying key genes and pathways. A comprehensive bioinformatics analysis revealed twelve hub genes (ETNK1, BICRA, IL1R1, KDM3A, ARID2, GSK3β, EZH2, NOTCH1, SMARCA4, FOS, CREB1, and CASP3) and highlighted their involvement in crucial oncogenic pathways, including PI3K/Akt, mTOR, MAPK, and TGF-β.

View Article and Find Full Text PDF

Survival and parenteral nutrition dependence in patients aged 65 and older with short bowel syndrome: a retrospective observational cohort study.

Am J Clin Nutr

March 2025

Assistance Publique-Hôpitaux de Paris (AP-HP), Department of Gastroenterology, IBD and Intestinal Failure, Beaujon Hospital, Clichy, France. Electronic address:

Background: Home parenteral support (PS) is the standard treatment for chronic intestinal failure (CIF) with short bowel syndrome (SBS) as the leading cause. However, outcomes of PS in older patients remain poorly studied.

Methods: This retrospective observational study evaluated patients newly diagnosed with SBS-CIF initiating PS between 2015 and 2020 at a national French CIF referral center.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!